Merck & Company, Inc. vs Tilray Brands, Inc. — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
4.4
Bearish
Quality
Health
Growth
Valuation
Sentiment
MRK
Forward P/E of 11.5× is low relative to sector peers.
TLRY
Consensus analyst target of $10.04 is 63% above current price.
⚠ currently unprofitable (-157% margin).
Analyst Consensus
BUY
Target $129.74 (+15.7%)
27 analysts
HOLD
Target $10.04 (+63.1%)
9 analysts
Fundamentals
MRK
TLRY
31.5×
Trailing P/E
—
11.5×
Forward P/E
22.7×
13.6%
Profit Margin
-156.7%
76.6%
Gross Margin
27.7%
—
ROE
-63.2%
4.9%
Revenue Growth
-7.8%
—
Earnings Growth
—
0.28
Beta
2.11
—
Price / Book
—
$277.0B
Market Cap
$737M
$73 – $125
52-Week Range
$4 – $23
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →